Tyra Bioscience (TYRA) Live Share Price, Invest From India

Tyra Bioscience Stock Performance

as on September 5, 2026 at 2:15 pm IST

Day's Low
Day's High
$24.51
Day's Price Range
$29.56
$28.65
14.45%
Downside
3.18%
Upside
52 Week's Low
52 Week's High
$11.70
52-Week Price Range
$40.65
$28.65
59.15%
Downside
41.88%
Upside

Tyra Bioscience share price movements today

Previous Close: $24.86
Open: $24.51
Volume: 2.1M
Market Cap: $1.5B
Day's Low - High: $24.51 - $29.56
52 Week Low - High: $11.70 - $40.65

Tyra Bioscience Historical Returns

1 Month Return: -23.58 %
3 Month Return: -8.54 %
1 Year Return: + 104.78 %
3 Year Return: + 65.73 %
5 Year Return: 0 %

Tyra Bioscience Stock Fundamentals & Key Indicators

Check Tyra Bioscience market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

-2.6729

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-159.9M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-45.31%

Tyra Bioscience vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tyra Bioscience with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Tyra Bioscience	BUY	$1.5B	NA	NA	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$141.1B	181.73%	32.21	86.04%	NA
Moderna	BUY	$60.2B	-64.27%	-18.66	-12.57%	NA
Regeneron	BUY	$84.8B	24.12%	20.14	84.86%	0.44%

Stock Returns calculator for Tyra Bioscience Stock including INR - Dollar returns

The Tyra Bioscience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Tyra Bioscience investment value today

Current value as on today

₹2,52,834

Returns

₹1,52,834

(+152.83%)

Returns from Tyra Bioscience Stock

₹1,35,997 (+136%)

Dollar Impact

₹16,837 (+16.84%)

Analyst Recommendation on Tyra Bioscience Stock

Based on 9 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 9 analysts, 100% of analysts recommend a 'BUY' rating for Tyra Bioscience. Average target price of $50.82

Tyra Bioscience Share Price Target

Get share price movements and forecasts by analysts on Tyra Bioscience.

What analysts predicted

43.62%UPSIDE

Target Price

$50.82

Current Price

$28.65

Analyzed by

9 Analysts

Target

$50.82

Tyra Bioscience target price $50.82, a slight upside of 43.62% compared to current price of $28.65. According to 9 analysts rating.

Indian Investors' Interest in Tyra Bioscience Stock

Search interest for Tyra Bioscience Stock has increased by 206% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 6, 2026 to September 5, 2026

Change:206% versus previous 30 day period

Tyra Bioscience Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	0	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-	0	0	-
Operating Income	-22	-23	-28	-29	-31	-31	-32	-36	-41	-49
EBITDA	-18	-18	-23	-25	-28	-27	-29	-33	-39	-45
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-18	-18	-24	-25	-28	-28	-29	-33	-39	-45
Income Tax Expense	0	-	-	-	-	-	-	-	-	-
Net Income	-18	-18	-24	-25	-28	-28	-29	-33	-39	-45
Net Profit Margin	0.00%	0.00%	0.00%	-5155.44%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tyra Bioscience Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-3	-9	-26	-58	-79	-104	-132
EBITDA	-3	-9	-26	-58	-68	-85	-119
Interest Expense	0	0	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-4	-9	-26	-55	-69	-86	-119
Income Tax Expense	0	0	0	-3	-	-	-
Net Income	-4	-9	-26	-51	-69	-86	-119
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Tyra Bioscience Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-18	-24	-25	-28	-28	-29	-33	-39	-45
Operating Cash Flow	-10	-17	-19	-25	-23	-22	-23	-32	-31
Investing Cash Flow	-144	21	6	32	20	-14	34	-120	17
Financing Cash Flow	0	0	0	2	0	0	4	160	2
Change in Cash	-154	4	-11	8	-2	-36	15	7	-11

Tyra Bioscience Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-9	-26	-55	-69	-86	-119
Operating Cash Flow	-7	-23	-50	-50	-69	-95
Investing Cash Flow	0	0	0	-144	-98	72
Financing Cash Flow	23	311	0	1	202	8
Change in Cash	15	286	-50	-193	33	-14

Mutual Funds that own Tyra Bioscience Stock

Check out the Mutual Funds with significant holdings in Tyra Bioscience.

Funds	Holdings	Shares Held
Fidelity Securities Fund	7.385933%	4407699
VANGUARD INDEX FUNDS	1.840878%	1098580
JANUS INVESTMENT FUND	0.930957%	555567
Fidelity Hastings Street Trust	0.886942%	529300
Fidelity Advisor Series VII	0.828125%	494200

See all

Global Institutional Holdings in Tyra Bioscience

Funds	Holdings
Peter Kolchinsky	20.44%
Andrew J.M. Spokes	6%
Vanguard	3.12%
iShares	2.99%
SPDR	2.72%

See all

Insights on Tyra Bioscience

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, TYRA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 7 days, TYRA stock has moved up by 14.9%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 479.0% return, outperforming this stock by 352.5%

About Tyra Bioscience

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.

Organisation	Tyra Bioscience
Headquarters	2656 State Street, Carlsbad, CA, United States, 92008
Industry	Biotechnology
CEO	Dr. Todd Harris Ph.D.
E-voting on shares	Click here to vote

Key Management of Tyra Bioscience

Name	Title
Mr. Ali D. Fawaz J.D.	General Counsel & Secretary
Ms. Sarah Honig	Senior VP of Corporate Development & Strategy
Dr. Todd Harris Ph.D.	Co-Founder, CEO, President & Director
Mr. Alan Fuhrman CPA	Chief Financial Officer
Ms. Julia Rueb	VP of Finance & Principal Accounting Officer
Dr. Robert L. Hudkins Ph.D.	Chief Technology Officer
Dr. Ronald V. Swanson Ph.D.	Chief Scientific Officer
Mr. Bhavesh Ashar M.B.A.	Chief Operating Officer
Dr. Douglas Warner M.D.	Chief Medical Officer
Mr. Daniel Bensen	Co-Founder & Chief Discovery Officer

FAQs

What is Tyra Bioscience share price today?

Tyra Bioscience share price today is $28.65 as on September 5, 2026 at 8:45 am IST at the close of the market. Tyra Bioscience share today touched a day high of $29.56 and a low of $24.51.

What is the 52 week high and 52 week low for Tyra Bioscience share?

Tyra Bioscience share touched a 52 week high of $40.65 on April 1, 2026 and a 52 week low of $11.70 on September 11, 2025. Tyra Bioscience stock price today i.e. September 5, 2026 at 8:45 am IST is closed at $28.65,which is 29.52% down from its 52 week high and 144.81% up from its 52 week low.

What is Tyra Bioscience's market capitalisation today?

Tyra Bioscience market capitalisation is $0.00T as on September 5, 2026 at 8:45 am IST.

How to invest in Tyra Bioscience Stock (TYRA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tyra Bioscience on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tyra Bioscience Shares that will get you 0.0524 shares as per Tyra Bioscience share price of $28.65 per share as on September 5, 2026 at 8:45 am IST.

What is the minimum amount required to buy Tyra Bioscience Stock (TYRA) from India?

Indian investors can start investing in Tyra Bioscience (TYRA) shares with as little as ₹94.485 or $1 (as of September 5, 2026 at 9:49 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Tyra Bioscience stock (as per the Rupee-Dollar exchange rate as on September 5, 2026 at 9:49 am IST). Based on Tyra Bioscience share’s latest price of $28.65 as on September 5, 2026 at 8:45 am IST, you will get 0.3490 shares of Tyra Bioscience. Learn more about fractional shares .